Sumitomo Life Insurance Co. Makes New Investment in AMETEK, Inc. $AME

Sumitomo Life Insurance Co. purchased a new position in shares of AMETEK, Inc. (NYSE:AME) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 9,915 shares of the technology company’s stock, valued at approximately $2,399,000.

Other large investors have also made changes to their positions in the company. Sivia Capital Partners LLC purchased a new position in AMETEK in the second quarter valued at about $295,000. Baird Financial Group Inc. boosted its stake in shares of AMETEK by 16.1% during the 2nd quarter. Baird Financial Group Inc. now owns 16,784 shares of the technology company’s stock worth $3,037,000 after acquiring an additional 2,323 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of AMETEK by 65.0% during the 2nd quarter. NewEdge Advisors LLC now owns 3,946 shares of the technology company’s stock worth $714,000 after acquiring an additional 1,555 shares in the last quarter. Sei Investments Co. grew its holdings in shares of AMETEK by 38.2% in the 2nd quarter. Sei Investments Co. now owns 223,227 shares of the technology company’s stock worth $40,392,000 after acquiring an additional 61,672 shares during the period. Finally, Squarepoint Ops LLC grew its holdings in shares of AMETEK by 105.3% in the 2nd quarter. Squarepoint Ops LLC now owns 158,274 shares of the technology company’s stock worth $28,641,000 after acquiring an additional 81,178 shares during the period. Hedge funds and other institutional investors own 87.43% of the company’s stock.

AMETEK Stock Performance

Shares of AME opened at $239.67 on Friday. AMETEK, Inc. has a 1 year low of $179.24 and a 1 year high of $261.16. The company’s 50 day simple moving average is $240.90 and its 200 day simple moving average is $231.99. The company has a market capitalization of $54.93 billion, a price-to-earnings ratio of 35.04, a PEG ratio of 3.06 and a beta of 0.98. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.76 and a current ratio of 1.21.

AMETEK (NYSE:AME) last released its earnings results on Tuesday, August 4th. The technology company reported $2.09 EPS for the quarter, topping the consensus estimate of $1.99 by $0.10. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $1.95 billion. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. AMETEK’s revenue for the quarter was up 15.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.78 EPS. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. On average, sell-side analysts predict that AMETEK, Inc. will post 8.32 EPS for the current year.

AMETEK Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, September 15th. AMETEK’s dividend payout ratio is presently 19.88%.

Insiders Place Their Bets

In other AMETEK news, insider David F. Hermance sold 6,608 shares of the firm’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $254.00, for a total value of $1,678,432.00. Following the sale, the insider directly owned 42,509 shares of the company’s stock, valued at approximately $10,797,286. This trade represents a 13.45% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.54% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on AME. Rothschild & Co Redburn set a $265.00 price objective on AMETEK in a report on Thursday, June 18th. Mizuho set a $270.00 price target on AMETEK in a research note on Friday, May 1st. KeyCorp boosted their price objective on shares of AMETEK from $260.00 to $295.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 5th. Morgan Stanley increased their price objective on shares of AMETEK from $235.00 to $245.00 and gave the company an “equal weight” rating in a research note on Friday, July 10th. Finally, BNP Paribas Exane lifted their target price on shares of AMETEK from $270.00 to $280.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, AMETEK presently has an average rating of “Moderate Buy” and an average price target of $266.80.

About AMETEK

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.